Tag archive for ‘Evista Raloxifene Tablets’
Jewish Business News On Tuesday, March 4th, 2014

Teva Announces Approval Of Generic Breast Cancer, Osteoporosis Drug Evista Tablets In The US

– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the approval from the US Food and More...

Wordpress site Developed by Fixing WordPress Problems